Intrinsic value of ReWalk Robotics - RWLK

Previous Close

$0.55

  Intrinsic Value

$0.03

stock screener

  Rating & Target

str. sell

-95%

Previous close

$0.55

 
Intrinsic value

$0.03

 
Up/down potential

-95%

 
Rating

str. sell

We calculate the intrinsic value of RWLK stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.0

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  32.10
  29.39
  26.95
  24.76
  22.78
  21.00
  19.40
  17.96
  16.67
  15.50
  14.45
  13.50
  12.65
  11.89
  11.20
  10.58
  10.02
  9.52
  9.07
  8.66
  8.29
  7.97
  7.67
  7.40
  7.16
  6.95
  6.75
  6.58
  6.42
  6.28
Revenue, $m
  10
  13
  17
  21
  26
  31
  37
  44
  51
  59
  68
  77
  87
  97
  108
  119
  131
  144
  157
  170
  184
  199
  214
  230
  247
  264
  281
  300
  319
  339
Variable operating expenses, $m
  63
  81
  103
  129
  158
  191
  228
  269
  314
  362
  415
  471
  530
  594
  660
  730
  803
  879
  959
  1,042
  1,129
  1,219
  1,312
  1,409
  1,510
  1,615
  1,724
  1,837
  1,955
  2,078
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  63
  81
  103
  129
  158
  191
  228
  269
  314
  362
  415
  471
  530
  594
  660
  730
  803
  879
  959
  1,042
  1,129
  1,219
  1,312
  1,409
  1,510
  1,615
  1,724
  1,837
  1,955
  2,078
Operating income, $m
  -52
  -68
  -86
  -108
  -132
  -160
  -191
  -225
  -263
  -303
  -347
  -394
  -444
  -497
  -552
  -611
  -672
  -736
  -803
  -872
  -944
  -1,020
  -1,098
  -1,179
  -1,263
  -1,351
  -1,442
  -1,537
  -1,636
  -1,739
EBITDA, $m
  -52
  -68
  -86
  -107
  -131
  -159
  -190
  -224
  -261
  -302
  -345
  -392
  -442
  -494
  -549
  -608
  -668
  -732
  -798
  -868
  -940
  -1,014
  -1,092
  -1,173
  -1,257
  -1,344
  -1,435
  -1,529
  -1,628
  -1,730
Interest expense (income), $m
  1
  2
  2
  3
  3
  4
  5
  6
  7
  8
  10
  11
  12
  14
  16
  18
  20
  22
  24
  26
  28
  31
  33
  36
  39
  41
  44
  47
  51
  54
  57
Earnings before tax, $m
  -55
  -70
  -89
  -111
  -136
  -165
  -197
  -232
  -271
  -313
  -358
  -406
  -458
  -512
  -570
  -630
  -693
  -760
  -829
  -900
  -975
  -1,053
  -1,134
  -1,218
  -1,305
  -1,396
  -1,490
  -1,588
  -1,690
  -1,796
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -55
  -70
  -89
  -111
  -136
  -165
  -197
  -232
  -271
  -313
  -358
  -406
  -458
  -512
  -570
  -630
  -693
  -760
  -829
  -900
  -975
  -1,053
  -1,134
  -1,218
  -1,305
  -1,396
  -1,490
  -1,588
  -1,690
  -1,796

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  15
  19
  24
  30
  37
  45
  54
  64
  74
  86
  98
  111
  125
  140
  156
  172
  190
  208
  227
  246
  267
  288
  310
  333
  357
  382
  407
  434
  462
  491
Adjusted assets (=assets-cash), $m
  15
  19
  24
  30
  37
  45
  54
  64
  74
  86
  98
  111
  125
  140
  156
  172
  190
  208
  227
  246
  267
  288
  310
  333
  357
  382
  407
  434
  462
  491
Revenue / Adjusted assets
  0.667
  0.684
  0.708
  0.700
  0.703
  0.689
  0.685
  0.688
  0.689
  0.686
  0.694
  0.694
  0.696
  0.693
  0.692
  0.692
  0.689
  0.692
  0.692
  0.691
  0.689
  0.691
  0.690
  0.691
  0.692
  0.691
  0.690
  0.691
  0.690
  0.690
Average production assets, $m
  1
  2
  2
  3
  3
  4
  5
  6
  7
  8
  9
  10
  11
  13
  14
  16
  17
  19
  21
  22
  24
  26
  28
  30
  32
  35
  37
  39
  42
  44
Working capital, $m
  4
  5
  6
  8
  10
  12
  14
  17
  20
  23
  26
  30
  33
  37
  42
  46
  51
  55
  60
  66
  71
  77
  83
  89
  95
  102
  109
  116
  123
  131
Total debt, $m
  16
  20
  25
  30
  36
  43
  51
  60
  69
  80
  91
  103
  115
  129
  143
  158
  173
  190
  207
  224
  243
  262
  282
  302
  324
  346
  369
  393
  418
  444
Total liabilities, $m
  13
  17
  22
  27
  34
  41
  48
  57
  67
  77
  88
  100
  113
  126
  140
  155
  171
  187
  204
  222
  240
  259
  279
  300
  321
  343
  367
  391
  416
  442
Total equity, $m
  1
  2
  2
  3
  4
  5
  5
  6
  7
  9
  10
  11
  13
  14
  16
  17
  19
  21
  23
  25
  27
  29
  31
  33
  36
  38
  41
  43
  46
  49
Total liabilities and equity, $m
  14
  19
  24
  30
  38
  46
  53
  63
  74
  86
  98
  111
  126
  140
  156
  172
  190
  208
  227
  247
  267
  288
  310
  333
  357
  381
  408
  434
  462
  491
Debt-to-equity ratio
  10.780
  10.380
  10.080
  9.870
  9.710
  9.580
  9.490
  9.410
  9.360
  9.310
  9.270
  9.240
  9.210
  9.190
  9.170
  9.150
  9.140
  9.130
  9.120
  9.110
  9.100
  9.090
  9.090
  9.080
  9.070
  9.070
  9.060
  9.060
  9.060
  9.050
Adjusted equity ratio
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -55
  -70
  -89
  -111
  -136
  -165
  -197
  -232
  -271
  -313
  -358
  -406
  -458
  -512
  -570
  -630
  -693
  -760
  -829
  -900
  -975
  -1,053
  -1,134
  -1,218
  -1,305
  -1,396
  -1,490
  -1,588
  -1,690
  -1,796
Depreciation, amort., depletion, $m
  0
  0
  0
  1
  1
  1
  1
  1
  1
  2
  2
  2
  2
  3
  3
  3
  3
  4
  4
  4
  5
  5
  6
  6
  6
  7
  7
  8
  8
  9
Funds from operations, $m
  -54
  -70
  -89
  -110
  -135
  -164
  -196
  -231
  -269
  -311
  -356
  -404
  -456
  -510
  -567
  -627
  -690
  -756
  -824
  -896
  -970
  -1,048
  -1,128
  -1,212
  -1,298
  -1,389
  -1,482
  -1,580
  -1,681
  -1,787
Change in working capital, $m
  1
  1
  1
  2
  2
  2
  2
  3
  3
  3
  3
  4
  4
  4
  4
  4
  5
  5
  5
  5
  5
  6
  6
  6
  6
  7
  7
  7
  7
  8
Cash from operations, $m
  -55
  -71
  -90
  -112
  -137
  -166
  -198
  -234
  -272
  -314
  -360
  -408
  -459
  -514
  -571
  -632
  -695
  -761
  -829
  -901
  -976
  -1,053
  -1,134
  -1,218
  -1,305
  -1,395
  -1,489
  -1,587
  -1,689
  -1,795
Maintenance CAPEX, $m
  0
  0
  0
  0
  -1
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -5
  -5
  -6
  -6
  -6
  -7
  -7
  -8
  -8
New CAPEX, $m
  0
  0
  0
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -3
  -3
Cash from investing activities, $m
  0
  0
  0
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -4
  -4
  -5
  -5
  -6
  -6
  -6
  -7
  -7
  -8
  -8
  -8
  -9
  -9
  -11
  -11
Free cash flow, $m
  -56
  -72
  -91
  -113
  -139
  -167
  -200
  -235
  -274
  -317
  -362
  -411
  -463
  -517
  -575
  -636
  -699
  -766
  -835
  -907
  -982
  -1,060
  -1,141
  -1,225
  -1,313
  -1,404
  -1,499
  -1,597
  -1,699
  -1,806
Issuance/(repayment) of debt, $m
  1
  4
  5
  5
  6
  7
  8
  9
  10
  10
  11
  12
  13
  13
  14
  15
  16
  16
  17
  18
  18
  19
  20
  21
  21
  22
  23
  24
  25
  26
Issuance/(repurchase) of shares, $m
  57
  71
  89
  112
  137
  166
  198
  233
  272
  314
  359
  408
  459
  514
  571
  632
  695
  761
  830
  902
  977
  1,055
  1,136
  1,220
  1,307
  1,398
  1,492
  1,591
  1,693
  1,799
Cash from financing (excl. dividends), $m  
  58
  75
  94
  117
  143
  173
  206
  242
  282
  324
  370
  420
  472
  527
  585
  647
  711
  777
  847
  920
  995
  1,074
  1,156
  1,241
  1,328
  1,420
  1,515
  1,615
  1,718
  1,825
Total cash flow (excl. dividends), $m
  2
  3
  3
  4
  5
  5
  6
  6
  7
  8
  8
  9
  9
  10
  10
  11
  11
  12
  12
  13
  13
  14
  15
  15
  16
  16
  17
  18
  18
  19
Retained Cash Flow (-), $m
  -57
  -71
  -89
  -112
  -137
  -166
  -198
  -233
  -272
  -314
  -359
  -408
  -459
  -514
  -571
  -632
  -695
  -761
  -830
  -902
  -977
  -1,055
  -1,136
  -1,220
  -1,307
  -1,398
  -1,492
  -1,591
  -1,693
  -1,799
Prev. year cash balance distribution, $m
  5
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -50
  -68
  -86
  -108
  -132
  -160
  -192
  -227
  -265
  -306
  -351
  -399
  -450
  -504
  -561
  -621
  -684
  -749
  -818
  -889
  -964
  -1,041
  -1,121
  -1,205
  -1,292
  -1,382
  -1,475
  -1,573
  -1,674
  -1,780
Discount rate, %
  5.80
  6.09
  6.39
  6.71
  7.05
  7.40
  7.77
  8.16
  8.57
  9.00
  9.45
  9.92
  10.42
  10.94
  11.48
  12.06
  12.66
  13.29
  13.96
  14.66
  15.39
  16.16
  16.97
  17.81
  18.71
  19.64
  20.62
  21.65
  22.74
  23.87
PV of cash for distribution, $m
  -48
  -60
  -71
  -83
  -94
  -104
  -114
  -121
  -126
  -129
  -130
  -128
  -124
  -118
  -110
  -100
  -90
  -79
  -68
  -58
  -48
  -39
  -30
  -24
  -18
  -13
  -9
  -7
  -4
  -3
Current shareholders' claim on cash, %
  50.0
  5.0
  0.5
  0.1
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.

FINANCIAL RATIOS  of  ReWalk Robotics (RWLK)

Valuation Ratios
P/E Ratio -0.3
Price to Sales 1.5
Price to Book 1.1
Price to Tangible Book
Price to Cash Flow -0.3
Price to Free Cash Flow -0.3
Growth Rates
Sales Growth Rate 50%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -100%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio 3
Current Ratio 0.1
LT Debt to Equity 125%
Total Debt to Equity 225%
Interest Coverage -32
Management Effectiveness
Return On Assets -110.3%
Ret/ On Assets - 3 Yr. Avg. -84.2%
Return On Total Capital -140.4%
Ret/ On T. Cap. - 3 Yr. Avg. -101.8%
Return On Equity -227.6%
Return On Equity - 3 Yr. Avg. -130.8%
Asset Turnover 0.2
Profitability Ratios
Gross Margin 16.7%
Gross Margin - 3 Yr. Avg. -2.8%
EBITDA Margin -516.7%
EBITDA Margin - 3 Yr. Avg. -563.9%
Operating Margin -500%
Oper. Margin - 3 Yr. Avg. -541.7%
Pre-Tax Margin -550%
Pre-Tax Margin - 3 Yr. Avg. -575%
Net Profit Margin -550%
Net Profit Margin - 3 Yr. Avg. -575%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

RWLK stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the RWLK stock intrinsic value calculation we used $7.753 million for the last fiscal year's total revenue generated by ReWalk Robotics. The default revenue input number comes from 0001 income statement of ReWalk Robotics. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our RWLK stock valuation model: a) initial revenue growth rate of 32.1% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 5.8%, whose default value for RWLK is calculated based on our internal credit rating of ReWalk Robotics, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of ReWalk Robotics.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of RWLK stock the variable cost ratio is equal to 612.5%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for RWLK stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 13.7% for ReWalk Robotics.

Corporate tax rate of 27% is the nominal tax rate for ReWalk Robotics. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the RWLK stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for RWLK are equal to 13.1%.

Life of production assets of 1.6 years is the average useful life of capital assets used in ReWalk Robotics operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for RWLK is equal to 38.6%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $3.707 million for ReWalk Robotics - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 35.483 million for ReWalk Robotics is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of ReWalk Robotics at the current share price and the inputted number of shares is $0.0 billion.

RELATED COMPANIES Price Int.Val. Rating
IVC Invacare 6.33 7.95  str.sell
HRC Hill-Rom Holdi 91.27 61.32  sell

COMPANY NEWS

▶ ReWalk Announces Placement of 500th Exoskeleton System   [Nov-09-18 08:02AM  PR Newswire]
▶ ReWalk: 3Q Earnings Snapshot   [05:02PM  Associated Press]
▶ VA now covering ReWalk exoskeleton for paralyzed veterans   [Aug-17-18 10:23AM  Fox Business Videos]
▶ ReWalk: 2Q Earnings Snapshot   [Aug-14-18 07:33AM  Associated Press]
▶ Why Rewalk Robotics (RWLK) Stock Is Skyrocketing Today   [Jul-20-18 03:45PM  InvestorPlace]
▶ ReWalk: 1Q Earnings Snapshot   [May-10-18 04:57PM  Associated Press]
▶ New exoskeleton designed to help stroke survivors walk   [Apr-05-18 10:24AM  Fox Business Videos]
▶ ReWalk reports 4Q loss   [Mar-08-18 07:33AM  Associated Press]
▶ Should You Buy ReWalk Robotics Ltd (NASDAQ:RWLK) At $1.15?   [Feb-26-18 06:33AM  Simply Wall St.]
▶ 4 Stocks to Buy at Their 52-Week Lows   [Nov-28-17 04:53PM  Zacks]
▶ 5 Breakout Stocks Offering Admirable Returns   [Nov-14-17 09:16AM  Zacks]
▶ ReWalk reports 3Q loss   [Nov-03-17 10:11AM  Associated Press]
▶ ReWalk Robotics Ltd. to Host Earnings Call   [Nov-02-17 07:00AM  ACCESSWIRE]
▶ Exoskeletons explained   [Oct-27-17 07:39AM  Reuters]
▶ ReWalk Robotics Launches Public Offering of Ordinary Shares   [Oct-17-17 07:45AM  GlobeNewswire]
▶ When Will ReWalk Robotics Ltd (RWLK) Come Back To Market?   [Oct-05-17 12:36PM  Simply Wall St.]
▶ Payer Coverage for ReWalk Expands in Germany with Barmer   [Sep-14-17 08:03AM  PR Newswire]
▶ ReWalk reports 2Q loss   [Aug-03-17 10:43AM  Associated Press]
▶ ReWalk Unveils Soft Suit Exoskeleton for Stroke Patients   [Jun-19-17 08:30AM  PR Newswire]
▶ ReWalk reports 1Q loss   [May-04-17 09:31AM  Associated Press]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.